• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

3',5'-环二鸟苷酸引发针对细菌感染的黏膜免疫。

3',5'-Cyclic diguanylic acid elicits mucosal immunity against bacterial infection.

作者信息

Yan Hongbin, KuoLee Rhonda, Tram Kha, Qiu Hongyu, Zhang Jianbing, Patel Girishchandra B, Chen Wangxue

机构信息

Department of Chemistry, Brock University, St. Catharines, Ontario, Canada.

出版信息

Biochem Biophys Res Commun. 2009 Sep 25;387(3):581-4. doi: 10.1016/j.bbrc.2009.07.061. Epub 2009 Jul 16.

DOI:10.1016/j.bbrc.2009.07.061
PMID:19615973
Abstract

3',5'-Cyclic diguanylic acid (cdiGMP) is emerging as a universal bacterial second messenger in regulating bacterial growth on surfaces. It has been recently shown that cdiGMP stimulates innate immunity and enhances antigen-specific humoral and cellular immune responses. We herein report that intranasal (i.n.) administration with cdiGMP induces an acute but transient inflammatory response and activation of dendritic cells in the lungs. Moreover, i.n. immunization of mice with pneumococcal surface adhesion A (PsaA) in conjunction with cdiGMP elicited strong antigen-specific serum immunoglobulin G (IgG) and secretory IgA antibody responses at multiple mucosal surfaces. More importantly, the immunized mice showed significantly reduced nasopharyngeal Streptococcus pneumoniae colonization. These results, for the first time, provide direct evidence for the induction of protection against mucosal bacterial infections by cdiGMP as an adjuvant.

摘要

3',5'-环二鸟苷酸(cdiGMP)作为一种通用的细菌第二信使,在调节细菌在表面的生长过程中逐渐崭露头角。最近的研究表明,cdiGMP可刺激先天免疫,并增强抗原特异性体液免疫和细胞免疫反应。我们在此报告,经鼻内(i.n.)给予cdiGMP会在肺部引发急性但短暂的炎症反应以及树突状细胞的激活。此外,将肺炎球菌表面黏附素A(PsaA)与cdiGMP联合经鼻内免疫小鼠,会在多个黏膜表面引发强烈的抗原特异性血清免疫球蛋白G(IgG)和分泌型IgA抗体反应。更重要的是,免疫后的小鼠鼻咽部肺炎链球菌定植显著减少。这些结果首次为cdiGMP作为佐剂诱导针对黏膜细菌感染的保护作用提供了直接证据。

相似文献

1
3',5'-Cyclic diguanylic acid elicits mucosal immunity against bacterial infection.3',5'-环二鸟苷酸引发针对细菌感染的黏膜免疫。
Biochem Biophys Res Commun. 2009 Sep 25;387(3):581-4. doi: 10.1016/j.bbrc.2009.07.061. Epub 2009 Jul 16.
2
The bacterial second messenger cdiGMP exhibits promising activity as a mucosal adjuvant.细菌第二信使环二鸟苷酸(cdiGMP)作为一种黏膜佐剂表现出有前景的活性。
Clin Vaccine Immunol. 2007 Aug;14(8):952-8. doi: 10.1128/CVI.00119-07. Epub 2007 Jun 13.
3
Mucosal immunization with polyamine transport protein D (PotD) protects mice against nasopharyngeal colonization with Streptococcus pneumoniae.用多胺转运蛋白D(PotD)进行黏膜免疫可保护小鼠免受肺炎链球菌的鼻咽部定植。
Exp Biol Med (Maywood). 2009 Apr;234(4):403-9. doi: 10.3181/0809-RM-269. Epub 2009 Jan 28.
4
Intranasal immunization with the cholera toxin B subunit-pneumococcal surface antigen A fusion protein induces protection against colonization with Streptococcus pneumoniae and has negligible impact on the nasopharyngeal and oral microbiota of mice.用霍乱毒素B亚基-肺炎球菌表面抗原A融合蛋白进行鼻内免疫可诱导对肺炎链球菌定植的保护作用,并且对小鼠的鼻咽和口腔微生物群影响可忽略不计。
Infect Immun. 2006 Aug;74(8):4939-44. doi: 10.1128/IAI.00134-06.
5
The bacterial second messenger cyclic diGMP exhibits potent adjuvant properties.细菌第二信使环二鸟苷酸具有强大的佐剂特性。
Vaccine. 2007 Feb 9;25(8):1464-9. doi: 10.1016/j.vaccine.2006.10.033. Epub 2006 Nov 3.
6
Immunoglobulin A and CD8 T-cell mucosal immune defenses protect against intranasal infection with Chlamydia pneumoniae.免疫球蛋白A和CD8 T细胞黏膜免疫防御可抵御肺炎衣原体的鼻内感染。
Scand J Immunol. 2006 Mar;63(3):177-83. doi: 10.1111/j.1365-3083.2006.01725.x.
7
Nasal administration of Lactococcus lactis improves local and systemic immune responses against Streptococcus pneumoniae.经鼻腔给予乳酸乳球菌可改善针对肺炎链球菌的局部和全身免疫反应。
Microbiol Immunol. 2008 Aug;52(8):399-409. doi: 10.1111/j.1348-0421.2008.00050.x.
8
Mucosal immunization with caseinolytic protease X elicited cross-protective immunity against pneumococcal infection in mice.酪蛋白内切酶 X 的黏膜免疫可诱导小鼠对肺炎球菌感染产生交叉保护免疫。
Exp Biol Med (Maywood). 2012 Jun;237(6):694-702. doi: 10.1258/ebm.2012.011383. Epub 2012 Jun 22.
9
Combined prime-boost immunization with systemic and mucosal pneumococcal vaccines based on Pneumococcal surface protein A to enhance protection against lethal pneumococcal infections.基于肺炎球菌表面蛋白 A 的系统和黏膜肺炎球菌疫苗联合加强免疫,增强对致死性肺炎球菌感染的保护作用。
Immunol Res. 2019 Oct;67(4-5):398-407. doi: 10.1007/s12026-019-09107-6.
10
Polyvalent 23 epitope polysaccharide pneumonia vaccine induced effective protection through strain-adapted effector mechanisms as demonstrated by the different cytokine responses in mice challenged with two different strains of Streptococcus pneumoniae.多价23表位多糖肺炎疫苗通过适应性菌株效应机制诱导有效保护,这在受到两种不同肺炎链球菌菌株攻击的小鼠中不同的细胞因子反应得到了证明。
Eur Cytokine Netw. 2007 Mar;18(1):23-30. doi: 10.1684/ecn.2007.0082. Epub 2007 Mar 30.

引用本文的文献

1
Comparative molecular, innate, and adaptive impacts of chemically diverse STING agonists.化学性质各异的STING激动剂的比较分子、固有和适应性影响。
Vaccine. 2025 Jun 14;61:127389. doi: 10.1016/j.vaccine.2025.127389.
2
Comparative Molecular, Innate, and Adaptive Impacts of Chemically Diverse STING Agonists.化学性质各异的STING激动剂的比较分子、先天性和适应性影响
bioRxiv. 2025 Feb 27:2025.02.21.639458. doi: 10.1101/2025.02.21.639458.
3
TLR agonists as vaccine adjuvants in the prevention of viral infections: an overview.Toll样受体激动剂作为预防病毒感染的疫苗佐剂:概述
Front Microbiol. 2023 Dec 21;14:1249718. doi: 10.3389/fmicb.2023.1249718. eCollection 2023.
4
STING Targeting in Lung Diseases.STING 靶向治疗肺部疾病。
Cells. 2022 Nov 3;11(21):3483. doi: 10.3390/cells11213483.
5
The role of bacterial cyclic di-adenosine monophosphate in the host immune response.细菌环二磷酸腺苷在宿主免疫反应中的作用。
Front Microbiol. 2022 Aug 29;13:958133. doi: 10.3389/fmicb.2022.958133. eCollection 2022.
6
2'-Fluoro-c-di-GMP as an oral vaccine adjuvant.2'-氟-c-二鸟苷单磷酸作为口服疫苗佐剂。
RSC Adv. 2019 Dec 16;9(71):41481-41489. doi: 10.1039/c9ra08310c. eCollection 2019 Dec 13.
7
Exploration of Pattern Recognition Receptor Agonists as Candidate Adjuvants.探索模式识别受体激动剂作为候选佐剂。
Front Cell Infect Microbiol. 2021 Oct 6;11:745016. doi: 10.3389/fcimb.2021.745016. eCollection 2021.
8
The Promise and Challenges of Cyclic Dinucleotides as Molecular Adjuvants for Vaccine Development.环二核苷酸作为疫苗开发分子佐剂的前景与挑战
Vaccines (Basel). 2021 Aug 17;9(8):917. doi: 10.3390/vaccines9080917.
9
Evaluation of Mucosal and Systemic Vaccine Responses by Cyclic di-GMP (CDG)-adjuvanted Protein Subunit Vaccines.环状二鸟苷单磷酸(CDG)佐剂蛋白亚单位疫苗对黏膜和全身疫苗反应的评估
Bio Protoc. 2019 Apr 20;9(8):e3217. doi: 10.21769/BioProtoc.3217.
10
New MoDC-Targeting TNF Fusion Proteins Enhance Cyclic Di-GMP Vaccine Adjuvanticity in Middle-Aged and Aged Mice.新型靶向树突状细胞的 TNF 融合蛋白增强了中老年小鼠环二鸟苷酸疫苗的佐剂活性。
Front Immunol. 2020 Aug 7;11:1674. doi: 10.3389/fimmu.2020.01674. eCollection 2020.